.
published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
.